Natco Pharma consolidated Q3 FY22 PAT climbs to Rs. 80.4 crores

Natco Pharma Limited has reported Consolidated financial results for the period ended December 31, 2021.

Financial Results (Q3 FY2022) - QoQ Comparison

The company has reported total income of Rs. 590.7 crores during the period ended December 31, 2021 as compared to Rs. 415.2 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs. 80.4 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 65.1 crores for the period ended September 30, 2021.

The company has reported EPS of Rs. 4.40 for the period ended December 31, 2021 as compared to Rs. 3.57 for the period ended September 30, 2021.

Financials	Q3 FY2022	Q2 FY2022	% Change
Total Income	₹ 590.7 crs	₹415.2 crs	42.27%
Net Profit	₹80.4 crs	₹65.1 crs	23.50%
EPS	₹4.40	₹3.57	23.25%

Financial Results (Q3 FY2022) - YoY Comparison

The company has reported total income of Rs. 590.7 crores during the period ended December 31, 2021 as compared to Rs.386 crores during the period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.80.4 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.62.7 crores for the period ended December 31, 2020.

The company has reported EPS of Rs.4.40 for the period ended December 31, 2021 as compared to Rs.3.43 for the period ended December 31, 2020.

Financials	Q3 FY2022	Q3 FY2021	% Change
Total Income	₹ 590.7 crs	₹386 crs	53.03%
Net Profit	₹80.4 crs	₹62.7 crs	28.23%
EPS	₹4.40	₹3.43	28.28%

Financial Results (9 Months Ended FY2022) - YoY Comparison

The company has reported total income of Rs.1433.2 crores during the 9 Months period ended December 31, 2021 as compared to Rs.1796 crores during the 9 Months period ended December 31, 2020.

The company has posted net profit / (loss) of Rs.220.5 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.387.9 crores for the 9 Months period ended December 31, 2020.

The company has reported EPS of Rs.12.08 for the 9 Months period ended December 31, 2021 as compared to Rs.21.25 for the 9 Months period ended December 31, 2020.

Financials	9 Months Ended FY2022	9 Months Ended FY2021	% Change
Total Income	₹1433.2 crs	₹1796 crs	-20.20%
Net Profit	₹220.5 crs	₹387.9 crs	-43.16%
EPS	₹12.08	₹21.25	-43.15%

Shares of Natco Pharma Limited was last trading in BSE at Rs. 896.55 as compared to the previous close of Rs. 918.80. The total number of shares traded during the day was 16711 in over 1475 trades.

The stock hit an intraday high of Rs. 936.50 and intraday low of 888.20. The net turnover during the day was Rs. 15311284.00.

Source : Equity Bulls

Keywords

NatcoPharma Q3FY22 9MFY22 ResultUpdate